Fluorocyanoacrylates
Folder:
Year:
Abstract:
This invention relates to compositions which polymerize to form coatings and adhesives. More particularly, the invention relates to fluorin-containing cyanoacrylate monomers which polymerize rapidly upon contact with basic materials or materials supplying hydroxyl ions, e.g. moisture in the air, to form polymers which are suitable for biological application, i.e. to bond or coat living mammalian tissues.
Type of document:
Language:
PATENT SPECIFICATION
N0 DRAWINGS
(W 1211172
'-‘.2
1211172
10
15'
20
25
30
35
40
(21) Application No. 56847/ 68
(3 1) Convention Application No. 687111
(33) United States of America (US)
(45) Complete Specification published 4 Nov. 1970
(51) International Classification C 07 c 121 / 30 A 61 k 9 / O0
(52) Index at acceptance
czc 1Q11E 1Q11G 1Q2 1Q6A1 1Q6-A2 1Q8A 1Q9D1
1Q9E
ASB 351 352 35Y 39X
(22) Filed 29 Nov. 1968
(32) Filed 1 Dec. 1967 in
B5N l7Y 184 195 22Y 234 245 250 252X 27OX 273X
2.74X 407 493 498 4-99 546 55Y 56X 669
C3P 8A 8D1B 8K11 8K8 8P1D 8P1X 8P2B 8P3 8P5
8P6X
(72) Inventors JERRY EARL ROBERTSON
JOSEPH KENNETH HARRINGTON and
ELDEN HARRIS BANITT
(54) FLUOROCYANOACRYLATES
(71) We, MINNESOTA MINING AND
MANUFACTURING COMPANY, a corporation of
the State of Delaware, United States o-f
America, of 2501 Hudson Road, Saint Paul,
Known non-fiuorinated alkyl 2 - cyano-
acrylates, particularly the methyl, isobutyl
and n — butyl 2 - cyanoacrylates, have been
investigated for use as biological adhesives,
Minnesota 55101, United States of America, see, e_g. Medical World News, 8 (20), 41 45
do hereby declare the invention, for which (1967); Mfg. Chemist, 38 (8), 94 (1967);
We pray that a patent may be granted to Technical Report 6618, Walter Reed Army
us and the method by which it is to be Medical Center, Dec., 1966. While the un-
performed, to be particularly described in substituted alkyl monomers appear to possess
and by the following statement:— the requisite bonding and hemostatic pro- 50
This invention relates to compositions parties when applied to damaged mammalian
which polymerize to form coatings and ad- tissues, these materials appear to fail to have
hesives. More particularly, the invention re- the required properties of low toxicity and
lates to fluorine-containing cyanoacrylate adequate absorption by the tissues. Methyl
monomers which polymerize rapidly upon 2. - cyanoacrylate, for example gives rise to 55
Contact with basic materials or materials a severe inflammatory tissue response at the
supplying hydroxyl ions, e.g. moisture in the site of application. The n - butyl and iso-
air, to- form polymers which are suitable for butyl 2. - cyanoacrylate monomers are not
biological application, i.e. to bond or coat absorbed well (if at all) by the tissues and
living mammalian tissues. polymeric residue of the adhesive has been 60
The fluorinated 2 - cyanoacrylates of this observed by histologic examination of the
invention are useful in adhesive compositions site of application as much as twelve months
and are particularly useful as biological ad— atfter surgery, see, e.g. Medical World News,
hesives and hemostatic agents. Thus, new 8 (29), 27 (1967).
approaches to- the joining together of This invention aims to provide new mono— 6'5
mammalian tissues, as well as for arresting mers which are suitable for use in b-iological
the escape of blood therethrough, are possible adhesive compositions and which form ad-
by the use of these novel monomers. For hesive bonds which do not significantly inter-
example, satisfactory hemostasis of splenic fere with natural healing of injured mam-
and liver wounds, heretofore to a great ex— malian tissues, are readily assimilated by the 70
tent unrepairable by conventional methods, is body with minimal toxic elfects, and are
obtained by the application and polymeriza- autopolymerizable in the presence of blood
tion of a thin fihn of fluorinated 2 — cyano- and other body fluids.
aczylate monomer on the injured surface. The The present invention also contemplates
bonding strength, absorbability by the tissues, providing new monomeric adhesives which 75
hemostatic capability and low degree of local can be used alone, or in co-njunction with
inflammation resulting when these monomers each other or in conjunction with unsub-
are applied in vivo, are properties which stituted alkyl 2 - cyanoacrylates in the bond-
make them especially valuable for biological ing of damaged mammalian tissue or in pre-
applications. venting the escape of blood or other fluids 80
[ Price
_i_______________________________________.__
10
15
20
25
30
35
45
1,211,172
therethrough and which are autopolymeriz-
able in thin film on said tissue. Comonomer
compositions are of interest for specific uses
because they may provide advantageous com-
binations of properties not completely em-
bodied in individual monomers.
Further contemplated by the invention is
the provision of new monomeric adhesives
which can be used either alone or as co-
monomers in the bonding of similar or dis-
similar materials without the use of heat or
catalyst during the bonding operation.
The present invention is based on the dis-
covery that the replacement of hydrogen
atoms in the alcoholic residue of 2 - cyano-
acrylate esters with fluorine atoms unex-
pectedly renders these monomers substanti-
ally better tolerated by living tissue than
are the hydrocarbon monomers.
The class of monomeric 2 - cyanoacrylate
esters which comprises this invention is re-
presented by the structural formula
CN R
I I
CH,=C—CO2—CH—CF,R’
wherein R is hydrogen, methyl or ethyl and
R’ is fluorine, —-(CF2),,H or CF, and n is
an integer from 1 to 3. These new fluorinated
monomers when employed in biological ad-
hesive compositions, individually or as co-
monomers, exhibit excellent skin wound ad-
hesion and hemostasis; they are well assimil-
ated by the tissues at an acceptable rate, and
their use, particularly in the case of the
monomers in which the
R
I
-CH—CF2R’
radical is
——~CHz(CF,),H,
—CH-_.C.F,CF3,
—-CH2(CF2)2H
and
—CH(CH,)C.F3,
produces minimal local tissue inflammation
in mammals. The —CH2CF, group-contain-
ing monomer, 2,2,2 - trifluoroethyl cyano-
acrylate, while exhibiting a relatively higher
degree of inflammatory tissue response in sub-
cutaneous tissues of mice, was completely
biodegraded by the exposed surface of parti-
ally excised rat livers within sixteen weeks
after application of the monomer. The degree
of local inflammation caused by the latter
monomer, however, is still less than that
caused by methyl 2 — cyanoacrylate as deter-
mined by gross and microscopic examina-
tions.
In most bonding applications employing
monomers of the invention, polymerization is
catalyzed by small amounts of moisture on
the surface of the adherends. Thus a drop
of monomer can b-e placed on the surface of
e.g. one of two metal or glass pieces which
are to be adhered and the other piece brought
into contact therewith. A strong bond is soon
formed by polymerization.
Similarly, desired bonding of tissues or
hemostasis proceeds well in the presence of
blood and other body fluids. The bonds
formed: are of adequate flexibility and
strength to withstand normal movement of
tissue. In addition, bond strength is main-
tained as natural wound healing proceeds
concurrently with polymer assimilation.
Compositions of the invention are steriliz-
able by conventional methods such as dis-
tillation under aseptic conditions.
The method of repairing injured tissues
with compositions of this invention (for ex-
ample, to control bleeding) comprises, in
general, sponging and subsequent application
to the tissue of an adhesive composition con-
taining a monomer of the invention which
polymerizes to a thin film of polymer while
in Contact with said tissue surfaces. For
bonding separate surfaces of body tissues, the
monomer would be applied to at least one
of such surfaces, and the surfaces brought
quickly together while the monomer poly-
merizes in contact with both of the surfaces.
The monomers of the invention are effec-
tive in adhesive formulations with the fluoro-
alkyl 2 — cyanoacrylates as the major active
constituent. Thus, the cyanoacrylate may be
combined in admixture with a polymeriza-
tion inhibitor (e.g. sulfur dioxide). One or
more adiuvant substances, such as thicken-
ing agents or plasticizers to improve the
surgical utility of the monomer, can also
be present.
Depending on the particular requirements
of the user, these adhesive compositions can
be applied by known means such as with
a glass stirring rod, sterile brush or medicinal
dropper; however, in many situations a pres-
surized aerosol dispensing package is pre-
fened in which the adhesive composition is
in solution with a compatible anhydrous pro-
pellant.
The monomers are readily polymerized to
addition-type polymers and copolymers,
which are generally optically clear (as films)
and are thermoplastic and moldable at tem-
peratures below their decomposition temp-
erature. They can be shaped at temperatures
in the range of 100° to 150°C.
The polymers have a
55
60
65
70
75
80
85
95
100
105
110
-3’
10
15
20
25
30
35
T40
45
50
55
1,211,172
wherein R and R’ are as defined above and
x is a number from 5 to 500.
Polymerization occurs by free radical in-
itiation, exposure to small amounts of base,
e.g. triethylamine, or water. The liquid mono-
mer can be spread on e.g. a polyethylene
surface and exposed to triethylamine to bring
about polymerization to a coating which can
be peeled from the polyethylene as a self-
supporting, optically clear film.
The monomers of the invention can be co-
polymerized with other acrylates or epoxides
for example, with an unsubstituted mono-
meric alkyl 2 - cyano-acrylate containing from
1 to 8 carbon atoms.
The preferred method for preparing high
purity (95 percent or greater) fluoroalkyl 2 -
cyanacrylates comprises catalytizing the con-
densation of formaldehyde with esters of
cyanoacetic acid by means of a mixture of
an acid and the acidic salt of an alkyl
primary or secondary amine.
With particular reference to the prepara-
tion of the fluoroalkyl 2 — cyanoacrylate esters
of the present invention, the preferred
method of preparation employs the cyano-
acetates corresponding to the desired cyano-
acrylates (e.g. 2,2,2 - trifluoroethyl cyano-
acetate for 2,2,2 — trifluoroethyl 2 - cyano-
acrylate). The cyanoacetate is reacted with
formaldehyde or polymers thereof such as
paraformaldehyde, excepting aqueous solu-
tions of formaldehyde as typified by formalin.
The reaction medium may be any suitable
inert organic solvent capable of forming an
azeotrope with water.
The essential feature of the synthesis is the
particular combination of catalytic materials
employed. Any acid salt of an alkyl primary
or secondary amine and any free acid may
be utilized as components of the catalytic
mixture, provided they establish the neces-
-sary pH value as described in detail below.
All phases o-f the synthetic sequence are
carried out under acidic conditions. A
criterion for utility of the catalytic mix-
ture selected is that it have a corrected pH
value of not over pH 5. This pH value can
be determined as follows.
The exact amounts of amine acid salt and
free acid to be used in the condensation step
are dissolved in 25 ml. of water, and the
pH of the solution is measured. If the result-
ing pH value is 5 or less, the mixture will
adequately catalyze the condensation reaction.
When the mixture is soluble in water, this is
the “corrected pH value”.
Catalytic mixtures comprising organic
acids which are not readily soluble in water
may be dissolved in 25 ml. of an ethanol-
water mixture; however, the measured pH
must then be corrected as described by B.
Gutbezehl and E. Grunwald in I. Am. Chem.
Soc., 75, 565 (1953).
Both primary or secondary amine salt and
free acid are always present. Glacial acetic
or strong mineral acids such as hydrochloric
acid or sulfuric acid are preferred. The
amount of catalyst employed is not critical
and may be varied. Ordinarily a small
amount, e.g. 0.5 to 0.1 percent by weight,
based on the weight of cyanoacetic ester, is
adequate.
Other than employing the amine acid salt
and free acid, the condensation of cyano-
acetic esters with formaldehyde and the sub-
sequent depolymerization process are carried
out by methods similar to prior art methods.
The following examples illustrate the in-
vention and its practical applications. It will
be understood, however, that the examples
are included merely for the purposes of illus-
tration and are not intended to limit the
scope of the invention, unless otherwise speci-
fically indicated. All parts are by weight un-
less otherwise specified, and the pressures
are shown in millimeters of mercury.
EXAMPLE 1
Fluoroalkyl cyanoacetates
Fluoroalkyl cyanoacetates required as
starting materials in the synthesis of fluoro-
alkyl 2 - cyanocrylates described in this in-
vention are not available by simple esteri-
fication of cyanoacetic acid. A general pro-
cedure fo-r the special preparation of these
materials from cyanoacetyl chloride on a
large scale is given below.
A 5-1 three-necked, round-bottomed flask
equipped with an efficient mechanical stirrer,
large addition funnel and reflux condenser
topped with a gas exit tube was charged
with 1000 ml. of diethyl ether and 1042.5 g.
of phosphorus pentachloride. This suspension
was stirred and cooled in an ice bath. In
a separate container, a solution of 425.5 g.
(5.0 moles) of cyanoacetic acid in 1750 ml.
-of diethyl ether was dried over magnesium
sulfate and filtered to remove drying agent.
It was then added over a period of 3 to 7
minutes with good stirring to the cold sus-
pension. (The exothermic reaction which
occurs can be controlled by adjusting the
rate of addition but a rapid rate is essential
for optimum yield). The condenser was im-
mediately replaced with a short head and
condenser. Ether and phosphorus oxychloride
were then distilled off under reduced pres- 5
sure (aspirator) to afford crude cyanoacetyl
chloride as an orange—red, mobile liquid.
During this operation, the internal pot tem-
perature was not allowed to exceed 55°C.
60
65
70
75
80
85
90
95
100
105
110
115
120
10
30
40
45
50
55
60
65
1,211,172
This step is critical since higher temperatures
will cause degradation of cyanoacetyl chloride
and may induce exothermic and uncontrol-
lable polymerization. Samples of cyanoacetyl
chloride should be used directly after pre-
paration and should not be stored.
The distillation apparatus was then re-
moved from the flask and replaced with a
reflux condenser topped with a gas exit tube.
The selected fluoroalcohol was placed in the
funnel and about one-third added to the
crude cyanoacetyl chloride. If the reaction
did not begin spontaneously as evidenced by
evolution of hydrogen chloride, the mixture
was heated to 55°—65°C; the remaining
fluoroalcohol was then added slowly to main-
tain a smooth reaction. After completion of
addition, the mixture was stirred at 55°-
65°C. until no more hydrogen chloride was
evolved. The acidic product was transferred
to a smaller flask and crudely distilled to
afford fluoroalkyl cyanoacetate. Fractional
redistillation provided pure fluoroalkyl cyano-
acetate with yields in the range of 75-85
percent.
TABLE I
Fluoroalkyl Cyanoacetates, NCCHZCOZR
R
—~CH2CF3
‘—'CH2CF2OF3
—CI-I2(-CF2)-2H
CH3
—CH
\
CFs
EXAMPLE 2
2,2,2-Trifluoroethyl 2-cyanoacrylate
Six hundred milliliters of benzene, 167.1
g. (1.0 mole of 2,2,2 - trifluoroethyl cyano-
acetate, 36.0 g. (1.2 moles) of powdered
paraformaldehyde, 1.0 g. of piperidine hydro-
chloride and 0.2 ml. of glacial acetic acid
were combined in a 1-1 two-necked, round
bottomed flask equipped with mechanical
stirrer, Dean-Stark water trap and reflux
condenser. The heterogeneous mixture was
stirred and heated under gentle reflux until
all water fonned during the reaction had been
azeotropically removed and collected in the
Dean-Stark trap. Only a portion of the poly-
(trifluoroethyl 2 - cyanoacrylate) formed in
the reaction separated; the remainder was
precipitated by cooling the flask in an ice
bath.
After the cold benzene had been decanted,
300 ml. of anhydrous acetone were added
and warmed to dissolve polymer. The clear
polymer solution was filtered (to remove
piperidine hydrochloride and any unreacted
paraformaldehyde) into a clean 1-l two-
necked, roimd bottomed flask equipped with
mechanical stirrer, and 100 g. of tricresyl
phosphate were added to aid in fluidizing the
mixture. Acetone was then removed by dis-
tillation. Pressure in the system was gradu-
ally reduced to 15-20 mm. Hg, and the
bath temperature slowly raised to 110°--
120°C. Last traces of acetone were elimin-
ated by stirring the yellow, viscous mixture
vigorously for 30 minutes under these condi-
l'.lOI1.S.
b.p (°C.)
93/9 mm.
83—85°C/6 mm.
71/0.25 mm.
105—106/0.9
96/13 mm.
nD25°
1.3692
1.3546
1.3785
1.3585
1.3724
At this point, 6-10 g. of polyphosphoric
acid and 0.5 g. of pyrogallol were added
to serve as inhibitors, and the flask was
equipped with a short take-off head fitted
with a gas inlet tube mounted in the thermo-
meter Well. Thermal depolymerization was
effected by heating this mixture under re-
duced pressure with good stirring while sul-
fur dioxide was bled into the system. Collec-
tion of monomeric 2,2,2 - trifluoroethyl 2 -
cyanoacrylate in a Dry Ice-cooled receiver
was begun when the bath temperature/
system pressure reached 155°C./20 mm. and
continued up to a maximum of 200°C/10
mm. Clear, colorless monomer obtained in
this fashion is sufliciently pure for most ad-
hesive applications; yield, 95 g. (53 percent
based on 2,2,2 - trifluoroethyl cyanocetate).
Greater purity may be achieved by re-
distillation from a amount of phos-
phorus pentoxide using a short Vigreux
column. A sulfur dioxide bleed to serve as
inhibitor and prevent anionic polymerization:
is essential during any such redistillation. On
redistillation, the distillation cut boiling at
83°—84°»C./13 mm. weighed 71 g. and was
shown to be 85.8 percent pure 2,2,2 - tri-
fluoroethyl 2 - cyanoacrylate.
Monomer purity was established by gas
chromatography using a chromatograph
equipped with a 6’X 1/4" nitrile-containing
silicone column packed on diatomaceous
earth (of the type commercially available
under the trade name “60/70 Anakrom
ABS”) and operated at column temperatures
of 150-190°C. Monomer samples were in-
15
20
25
70
75
80
85
90
95
100
110
§_j...j_
10
15
20
25
30
35
40
45
50
55
60
1,211,172
jected as 10 percent solutions in spectrograde
nitromethane.
Polymeric 2,2,2 - trifluoroethyl cyano-
acrylate was formed by pouring the monomer
into a large excess of rapidly stirred 1: 1
methanol-water solution. The polymer pre-
cipitated in finely divided form and was re-
moved by filtration, Washed with methanol
and dried. This was molded into disks at
about 100°—125°C. which have useful di-
electric properties. These disks can be
machined and used as insulating washers.
The polymer is soluble in acetone and films
o-r coatings can be made from these solu-
tions in the usual manner. These also have
useful electrical insulating properties.
EXAMPLE 3
2—(1,1,1-Trifluoro)propyl 2-cyanoacrylate
A 2-1 three-necked flask equipped with
a mechanical stirrer and Dean-Stark water
trap was charged with 438 g. (2.42 moles)
2 - (1,1,1 - trifluoro)propyl cyanoacetate,
96.0 g. (3.2 moles) powdered parafo-rmalde-
hyde, 3.0 g. piperidine hydrochloride, 0.5
ml. glacial acetic acid and 900 ml. benzene.
The mixture was stirred and slowly brought
to reflux over a period of 3 hours. Heating
under reflux was continued until no more
water separated in the trap. The cooled solu-
tion of low molecular weight polymer was
then filtered into a. round-bottomed flask con-
taining 240 .g. tricresylphosphate. Benzene
was then removed by distillation. Last traces
of solvent were eliminated by stirring the
mixture of 110°C. 0.3 mm.
The distillation head was removed and
replaced with a clean, dry one-piece head
and condenser fitted with a gas inlet tube
in the thermometer well. About 10 g. poly-
phosphoric acid were added to the orange
syrupy mixture. Thermal depolymerization
was affected by heating this mixture under
reduced pressure while sulfur dioxide was
bled into the system. Collection of crude
monomeric 2 — (1,1,1 - trifluoro)propyl 2 -
cyanocrylate in a Dry Ice—cooled receiver was
begun when the bath tiemperatiire/{system
pressure reached 150°-C./20 mm. and con-
tinued up to a maximum of 190°C./0.45
mm.; yield, 251 g. On redistillation of crude
monomer from a small amount of phosphorus
pentoxide as described in Example 1, the
fraction boiling at 83°—85°C./ 17 mm. was
shown to be at least 98 percent pure 2 —
(1,1,1 - trifluoro)propyl cyanoacrylate. The
monomer is converted to polymer by the pro-
cedure described in Example 1.
Examples of other 2-cyanoacrylates
Other cyanoacrylates which have been pre-
pared in a manner similar to that described
in Examples 1 and 2 are collected in Table
II.
TABLE II
CN
Fluoroalkyl 2-cyanoacrylates, CH2=C
- \
CO2R
R b.p.
-—CH2(CF2)2H 89—90/0.3 mm.
—CH2(CF2).,H 91——95/0.2-0.4 mm.
-—CH2-CFZCF3 98—-100°/ 15 mm.
These monomers can be polymerized in
the same manner as described in Examples
1 and 2.
EXAMPLE 4
Hemostasis in Vascular Organs (Excised Cat
Spleen)
A male cat was anesthetized intravenously
with pento-b-arbital—sodium and prepared for
aseptic surgery. Prior to surgery 25 milli-
grams of heparin sodium USP were intra-
venously administered. The spleen was ex-
teriorized through a ventral midline incision,
and a disk-shaped portion of splenic tissue
1 to 2 centimeters in diameter and 3 to 5
millimeters deep was excised. Resulting pro-
fuse hemorrhage from the wound was con-
trolled by occluding the blood supply to- the
spleen with soft clamps and gauze spong-
ing. A thin layer of 2,2,2 - trifluoroethyl 2 -
cyanoacrylate adhesive monomer was applied
to the wound surface immediately thereafter
by spraying with an aerosol at a distance of
from 4 to 8 centimeters from the wound
surface. After allowing suflicient time for
polymerization of the monomer, the organ
was replaced in the peritoneal cavity. The
ventral midline incision was closed using con-
ventional sutures. 1’-ost—operative antibiotics
and vitamins were routinely administered.
Adhesive and hemostatic properties were re-
corded at the time of application.
The cat, except for depression during the
first few post-operative days, made an un-
eventful recovery and remained healthy until
sacrified six weeks after surgery. Adhesions
between the spleen and surrounding tissue,
and expected sequela following surgery of
this nature, and mild inflammation of the
splenic capsule were the only gross tissue
changes observed at necropsy. None of the
adhesive was grossly visible and normal heal-
ing appeared to be in progress.
WHAT WE CLAIM IS:—
1. Compounds having the formula
CN R
I I
CH2=C—CO2——C.H——CF2R1
wherein R is hydrogen, methyl or ethyl; R1
is fluorine, —(CF2),,H or -—CF3; and n is an
integer of from 1 to 3.
5
65
70
75
80
85
90
95
100
105
110
115
6 3 Mn: .=nl. E
10
15
20
1,211,172
2. A compound of claim 1 wherein R is
hydrogen and R1 is fluorine.
3. A compound of claim 1 wherein R is
hydrogen and R1 is ——(GF2)3H.
4. A compound of claim 1 wherein R is
hydrogen and R1 is —CF,,.
5. A compound of claim 1 wherein R is
hydrogen and R1 is CF21-I.
6. A compound of claim 1 wherein R is
—(I’.I-I3 and R1 is fluorine.
7. A compound according to any of the
preceding claims in sterile form.
8. An adhesive composition which is auto-
polymerizable comprising a monomeric 2 -
cyanoacrylate having the formula
CN R
I I
CH,=C—CO2—CH—CF,R1
wherein R is hydrogen, methyl or ethyl; R1
is fluorine, —(CF2),,H or —CF,,; and n is
an integer of from 1 to 3, said adhesive com-
position containing an amount of polymeriza-
tion inhibitor as a stabilizer therefor.
9. An adhesive composition according to
claim 8 containing one or more of the com-
pounds according to claims 2—6.
Printed for Her Ma.jesty’s Stationery Office,
Published by The Patent Oflice, 25 Southampton
10. A composition according to claim 8
in which the polymerization inhibitor is sul-
fur dioxide.
11. An adhesive composition which is auto-
polymerizable comprising a mixture of at
least two of the compounds of any of claims
1—7 containing an amount of polymerization
inhibitor as a stabilizer therefor.
12. An adhesive composition according to
claim 8 which is autopolymerizable in thin
film, containing in admixture unsubstituted
monomeric alkyl 2 — cyanoacrylate contain-
ing from 1 to 8 carbon atoms.
13. A composition according to claim 8
containing an adiuvant material.
14. A cyanoacrylate compound according
to any one of the examples 2 or 3.
15. A thermoplastic addition polymer of
211 monomer according to any one of claims
—-7.
16. A thermoplastic addition polymer of a
monomer according to any one of examples
Zor 3.
REDDIE & GROSE,
Agents for the Applicants,
6 Bream’s Buildings,
London, E.C.4.
by the Courier Press, Leamington Spa, 1970.
Buildinfis, London, WC2A IAY, from
which copies may be obtains
6
25
35
45
Coments go here:
- Log in to post comments